Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.73 |
| ▸ | MAPT | P10636 | 7/20 | 0.73 |
| ▸ | NPC1 | O15118 | 6/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.73 |
| ▸ | MEN1 | O00255 | 5/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.73 |
| ▸ | TP53 | P04637 | 5/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.73 |
| ▸ | HPGD | P15428 | 4/20 | 0.73 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.73 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.73 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.73 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.73 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.73 |
| ▸ | RELA | Q04206 | 3/20 | 0.73 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pratensein SCHEMBL29349666 | 1.00 | RAB9A (0.73) | RAB9AMAPTNPC1KDM4EMEN1 | |
| Pratensein SCHEMBL29564983 | 1.00 | RAB9A (0.73) | RAB9AMAPTNPC1KDM4EMEN1 | |
| Pratensein SCHEMBL28502274 | 0.99 | RAB9A (0.72) | RAB9AMAPTNPC1KDM4EMEN1 | |
| SCHEMBL30380678 | 0.93 | ABCB1 (0.76) | RAB9AMAPTNPC1KDM4EMEN1 | |
| 3'-O-Methylorobol SCHEMBL30380427 | 0.90 | MAPT (0.73) | RAB9AMAPTNPC1KDM4EMEN1 | |
| 3'-O-Methylorobol SCHEMBL30380012 | 0.90 | MAPT (0.73) | RAB9AMAPTNPC1KDM4EMEN1 | |
| 3'-O-Methylorobol SCHEMBL13730131 | 0.90 | MAPT (0.73) | RAB9AMAPTNPC1KDM4EMEN1 | |
| SCHEMBL11561656 | 0.87 | MAPT (0.63) | RAB9AMAPTNPC1KDM4EMEN1 | |
| SCHEMBL28740045 | 0.85 | PTPN1 (0.70) | RAB9AMAPTNPC1KDM4EMEN1 | |
| Biochanin SCHEMBL61258 | 0.85 | RAB9A (1.00) | RAB9AMAPTNPC1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025049883-A1 | COMPOSITIONS AND METHODS FOR TREATING A DISEASE OR DISORDER ASSOCIATED WITH SENESCENCE | JLM EXOGRADE, LLC (US) | 2025-03-06 | — | — | WO | claimed |
| US-20240374554-A1 | ISOFLAVONE DERIVATIVES MODULATING MUTANT BESTROPHIN 1 FOR TREATMENT OF BEST1-RELATED RETINOPATHIES | UNIVERSITÄT REGENSBURG (DE) | 2024-11-14 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| EP-4408415-A1 | ISOFLAVONE DERIVATIVES MODULATING MUTANT BESTROPHIN 1 FOR TREATMENT OF BEST1-RELATED RETINOPATHIES | Universität Regensburg (DE) | 2024-08-07 | — | — | EP | claimed |
| US-20240042396-A1 | Polymeric Membrane | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-02-08 | — | — | US | claimed |
| EP-4259316-A2 | POLYMERIC MEMBRANE | 3M Innovative Properties Company (US) | 2023-10-18 | — | — | EP | claimed |
| WO-2023150072-A1 | COMPOSITIONS AND METHODS FOR THE PRESERVATION OF PLANT MATTER | SINCLAIR DAVID A (US) | 2023-08-10 | — | — | WO | claimed |
| WO-2023052579-A1 | ISOFLAVONE DERIVATIVES MODULATING MUTANT BESTROPHIN 1 FOR TREATMENT OF BEST1-RELATED RETINOPATHIES | UNIVERSITÄT REGENSBURG (DE) | 2023-04-06 | — | — | WO | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| CN-115299346-A | Method for improving alkaloid and flavone contents of subprostrate sophora tissue culture seedlings by using magnesium | 广西壮族自治区药用植物园 | 2022-11-08 | — | — | CN | claimed |
| EP-1392239-A2 | USE OF ISOFLAVONOIDS IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE PROPHYLAXIS OR TREATMENT OF SENSITIVE SKIN | Beiersdorf AG (DE) | 2004-03-03 | — | — | EP | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| US-20030147980-A1 | Extraction of flavonoids | MAABAROT PROJECT LAUNCHING AND MANAGEMENT LTD. (IL) | 2003-08-07 | — | — | US | claimed |
| EP-1254131-A4 | EXTRACTION OF FLAVONOIDS | BIOREX HEALTH LTD (AU) | 2003-04-23 | — | — | EP | claimed |
| CN-1395573-A | Extraction of flavonoids | BIOREX HEALTH LTD (AU) | 2003-02-05 | — | — | CN | claimed |
| WO-2002087517-A2 | USE OF ISOFLAVONOIDS IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE PROPHYLAXIS OR TREATMENT OF SENSITIVE SKIN | BEIERSDORF AG (DE) | 2002-11-07 | — | — | WO | claimed |
| EP-1254131-A1 | EXTRACTION OF FLAVONOIDS | Biorex Health Limited (AU) | 2002-11-06 | — | — | EP | claimed |
| US-20020107282-A1 | Cosmetic composition containing an aminophenol derivative and an isoflavonoid | L'OREAL (FR) | 2002-08-08 | — | — | US | claimed |
| CN-1352935-A | Cosmetics composition containing aminophenol derivatives and isoflavone like substance | OREAL (FR) | 2002-06-12 | — | — | CN | claimed |
| WO-2001051482-A1 | EXTRACTION OF FLAVONOIDS | BIOREX HEALTH LIMITED (AU) | 2001-07-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020107282-A1 | Cosmetic composition containing an aminophenol derivative and an isoflavonoid | TYR, CYP19A1, EYA3 | RAB9A 3324/4885MAPT 3061/4885NPC1 4489/4885 |
| US-20030147980-A1 | Extraction of flavonoids | ENGASE, GUSB, TYR | RAB9A 1560/4885MAPT 2033/4885NPC1 685/4885 |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | RAB9A 1281/4885MAPT 3926/4885NPC1 105/4885 |
| US-20240374554-A1 | ISOFLAVONE DERIVATIVES MODULATING MUTANT BESTROPHIN 1 FOR TREATMENT OF BEST1-RELATED RETINOPATHIES | PEAK1, ING2, TEKT1 | RAB9A 3261/4885MAPT 1810/4885NPC1 1232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.